Skip to content
Litigation Tracker Logo
  • Litigation
  • Issues
  • About
Login to your account
Issue / Topic: Prescription Drug Pricing

Drug Specific Access Laws

Tracker Trends
Trends Overview ›
340B Program21
Equity53
  • Affordable Care Act (Section 1557)27
Federal Health Funding59
  • Funding Termination/Cuts30
  • Health Information2
  • Indirect Cost Rate Cuts7
  • Medicaid12
  • Reproductive Health12
Health Care Affordability64
  • Anticompetitive Practices29
    • Anticompetitive Contracting10
    • Insurer Practices6
    • Provider Consolidation11
  • Cost Containment15
  • Medical Debt4
  • Site-Neutral Payments9
  • Staffing Standards7
Medicare Advantage38
  • Artificial Intelligence2
  • Coding Practices10
  • Coverage Denials6
  • Enrollment Practices1
  • Star Ratings21
Prescription Drug Pricing43
  • Drug Specific Access Laws5
  • Drug Transparency Laws2
  • Medicare Drug Price Negotiation24
  • Prescription Drug Affordability Boards4
  • Price Gouging Laws7
Private Health Insurance115
  • Affordable Care Act46
    • Copay Accumulators3
    • Employer Mandate2
    • Marketplace Rules11
    • Non-ACA Coverage12
    • Preventive Services16
  • Artificial Intelligence1
  • Ghost Networks7
  • No Surprises Act59
    • Arbitration Awards/Conduct40
    • Arbitration Regulations10
    • Constitutional Challenges5
    • Qualifying Payment Amount5
Reproductive Health54
  • EMTALA7
  • Federal Health Funding12
  • HIPAA Privacy Protections5
  • Medication Abortion18
  • Right to Travel7
Transparency and Quality9
5 tracked cases
Sub Issues
  • Overview
  • Medicare Drug Price Negotiation (24)
  • Price Gouging Laws (7)
  • Drug Specific Access Laws (5)
  • Prescription Drug Affordability Boards (4)
  • Drug Transparency Laws (2)

Litigation trends for Drug Specific Access Laws

Who's Suing

Plaintiff by Type

Who's Being Sued

Defendant by Type

Who's Suing

Plaintiff by Type

Who's Being Sued

Defendant by Type

Legal Issues

Statutes & Doctrines Cited

Legal Issues

Statutes & Doctrines Cited

Geographic Trends

2 active district courts

2 active circuit courts

  • 1st Circuit
  • 2nd Circuit
  • 3rd Circuit
  • 4th Circuit
  • 5th Circuit
  • 6th Circuit
  • 7th Circuit
  • 8th Circuit
  • 9th Circuit
  • 10th Circuit
  • 11th Circuit
  • D.C. Circuit
  • Fed. Circuit

Not shown: Puerto Rico (First Circuit), the U.S. Virgin Islands (Third Circuit), and Guam and the Northern Mariana Islands (Ninth Circuit).

Court Level

Appellate District
2 (40%) 3 (60%)

Status

Who's Presiding

District Court Cases by Appointing President

Reflects district court judges only.

All trend data is based solely on the cases on this website; if you want to recommend a new case to include, please let us know at hpli@georgetown.edu.

Drug Specific Access Laws Cases We're Tracking

Filter and Sort Litigation


Search Tips

The search supports the following:

  • Use quotation marks to search for an exact phrase (e.g., “No Surprises Act”).
  • Use plus (+) to search for required words (e.g., hospitals +transparency).
  • Use minus (-) to exclude specific words (e.g., hospitals -Medicare).
  • Search using docket numbers, including partial digits work (e.g., 1433 finds 3:25-cv-01433).

Active cases always appear first. Note that search results are limited to the information on case pages and do not include court filings. If you need assistance, please contact hpli@georgetown.edu.

, displayed in a grid view

21-1731

Pharmaceutical Research and Manufacturers of America v. Stuart Williams, et al.

Filed:
April 1, 2021
Status
Decision issued
Court
Eighth Circuit
Goal
Block enforcement of a law +1 additional goal(s)
  • Prescription Drug Pricing
  • Drug Specific Access Laws

1:24-cv-02609

Amneal Pharmaceuticals LLC v. Weiser et al.

Filed:
September 20, 2024
Status
Briefing is ongoing
Court
Colorado
Goal
Block enforcement of a law +1 additional goal(s)
  • Prescription Drug Pricing
  • Drug Specific Access Laws
Inactive Case

24-1035

Teva Pharmaceuticals USA Inc. v. Weiser et al.

Filed:
January 29, 2024
Status
Decision issued
Court
Tenth Circuit
Goal
Block enforcement of a law +1 additional goal(s)
  • Prescription Drug Pricing
  • Drug Specific Access Laws
Inactive Case

0:20-cv-01497

Pharmaceutical Research and Manufacturers of America v. Chakolis et al.

Filed:
June 30, 2020
Status
Case Dismissed
Court
Minnesota — Fourth
Goal
Block enforcement of a law +1 additional goal(s)
  • Prescription Drug Pricing
  • Drug Specific Access Laws
Inactive Case

1:23-cv-02584

Teva Pharmaceuticals USA, Inc. v. Weiser et al.

Filed:
October 3, 2023
Status
Case Dismissed
Court
Colorado
Goal
Block enforcement of a law +1 additional goal(s)
  • Prescription Drug Pricing
  • Drug Specific Access Laws

    Litigation Tracker Logo
    • Litigation
    • Legal Issues
    • About
    • Login
    • Privacy Policy

    O’Neill Institute for National and Global Health Law
    Georgetown University Law Center
    600 New Jersey Avenue, NW Washington, DC 20001
    Phone: (202) 662-9203 | Fax: (202) 662-4045

    Designed & built by Iced Coffee, Please.

    © All Content Copyright O'Neill Institute for National and Global Health Law or Georgetown University
    Return to the top of the page